Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis

Tetracycline-based histological analysis of bone remodeling

1969 • 1,107 citations

Modifications of a specific assay for hydroxyproline in urine

1967 • 1,091 citations

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.

1992 • 443 citations

Thyrocalcitonin: Inhibitor of Bone Resorption in Tissue Culture

1965 • 367 citations

Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

1988 • 364 citations

Long-term calcitonin therapy in postmenopausal osteoporosis

1984 • 332 citations

Tetracycline double-labeling of iliac trabecular bone in 41 normal adults

1978 • 231 citations

Histomorphometric Analysis of Normal Bone From the Iliac Crest

1978 • 208 citations

1-YEAR CONTROLLED RANDOMISED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONIN

1987 • 203 citations

A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis

1989 • 194 citations

Reconstruction of the resorptive site in iliac trabecular bone: A kinetic model for bone resorption in 20 normal individuals

1984 • 193 citations

Effect of salcatonin given intranasally on early postmenopausal bone loss.

1989 • 180 citations

NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSIS

1989 • 169 citations

Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis

1993 • 160 citations

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss

1995 • 87 citations

Effect of intranasal salmon calcitonin therapy on bone mass and bone turnover in early postmenopausal women: A dose-response study

1994 • 85 citations

An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss

1992 • 74 citations

Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin

1994 • 70 citations

Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin

1993 • 64 citations

Effect of different doses of nasal salmon calcitonin on bone mass

1991 • 63 citations

Effects of calcitonin on bone quality and osteoblastic function

1993 • 52 citations

Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects.

1987 • 48 citations

Quantitation of urinary hydroxypyridinium cross-links from collagen by high-performance liquid chromatography

1992 • 42 citations

Reconstruction of the formative site in trabecular bone by a new, quick, and easy method

1992 • 34 citations

Effect of calcitonin on bone histomorphometry and bone metabolism in rheumatoid arthritis

1992 • 31 citations

Effects of continuous and cyclic nasal calcitonin administration in ovariectomized women

1992 • 23 citations

Circulating levels of calciotropic hormones during treatment with nasal salmon calcitonin

1991 • 9 citations

Bone remodeling during calcitonin excess: Reconstruction of the remodeling sequence in medullary thyroid carcinoma

1993 • 4 citations

91271981 Circulating levels of calciotropic hormones during treatment with nasal salmon calcitonin

1992 • 1 citations